Methods for modulating cancer cells and stem cells
AssigneeThe Scripps Research Institute
InventorsPeter W. VANDERKLISH, Christina SPEVAK
Life of this patent
Estimating the term…
Abstract
The present invention provides methods for modulating pluripotency of stem cells and proliferation of cancer cells. The modulation is achieved by promoting dephosphorylation of mRNA-binding protein 3 (RBM3) and down-regulating expression or cellular level of pluripotency factor LIN28. Related methods are provided in the invention for promoting differentiation of stem cells and for inhibiting growth of tumors in subjects. The therapeutic methods of the invention typically entail contacting with a target cell (e.g., a tumor cell) or administering to a subject harboring the target cell a calpain inhibitor and/or an IGF1R inhibitor. Some methods of the invention employ both a calpain inhibitor and an IGF 1R inhibitor.
Claims21
A method for inhibiting phosphorylation, downregulating cellular level of phosphorylated form, or upregulating cellular level of dephosphorylated form, of mRNA-binding protein 3 (RBM3) in a target cell, comprising contacting the target cell with (1) a calpain inhibitor or (2) an IGF1R inhibitor, thereby inhibiting phosphorylation, down-regulating phosphorylated RBM3 or upregulating de-phosphorylated RBM3 in the target cell.
A method for down-regulating expression or cellular level of pluripotency factor LIN28 in a target cell, comprising contacting the target cell with (1) a calpain inhibitor or (2) an IGF1R inhibitor, thereby down-regulating expression or cellular level of pluripotency factor LIN28 in the target cell.
A method for treating or inhibiting the growth of a cancer in a subject, comprising administering to a subject in need of treatment a pharmaceutical composition comprising (1) a calpain inhibitor and/or (2) an IGF1R inhibitor, thereby treating or inhibiting the growth of a cancer in the subject.
21-30. (canceled)
Dependencies are inferred from the claim text.